CapitalBio Technology

company

About

CapitalBio Technology is a life science company that develops and commercializes health-care solutions.

  • 1001 - 5000

Details

Last Funding Type
Series A
Last Funding Money Raised
¥10M
Industries
AgTech,Biotechnology,Health Care,Life Science
Founded date
Aug 17, 2012
Number Of Employee
1001 - 5000
Operating Status
Active

CapitalBio Technology is an industry-leading life science company that develops and commercializes total health-care solutions. Their company provides a comprehensive portfolio of top-quality products to a diverse customer base ranging from biomedical researchers to healthcare professionals. Their products include an innovative and broad spectrum of microarray and microfluidic chips and related instruments, software and databases, reagents and consumables for basic and translational research, drug development, clinical diagnostics, biosafety and food safety, and molecular breeding.



As a core subsidiary of CapitalBio Corporation and the Biological Chip Beijing National Engineering Research Center, CapitalBio Technology was registered in August 2012 and is headquartered in Economic-Technological Development Area in Beijing. CapitalBio Technology is a leading life science company that develops and commercializes total health-care solutions. With more than 35,000 square meters of office space, CapitalBio Technology employs more than 500 employees; 86 percent of these employees have at least Bachelor-level degrees, 14 of which are doctors or post-doctorates.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
¥833M
CapitalBio Technology has raised a total of ¥833M in funding over 2 rounds. Their latest funding was raised on Jun 29, 2020 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 29, 2020 Series C ¥800M 6 Guangdong Boyi Jianzhu Shejiyuan Detail
Dec 18, 2017 Series B ¥20M 9 Detail
Jun 7, 2016 Series A ¥10M 5 Detail
Aug 17, 2012 Angel ¥3M 2 Detail